698 related articles for article (PubMed ID: 38791164)
1. Skeletal Muscle Injury in Chronic Kidney Disease-From Histologic Changes to Molecular Mechanisms and to Novel Therapies.
Heitman K; Alexander MS; Faul C
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791164
[TBL] [Abstract][Full Text] [Related]
2. Metabolic alterations by indoxyl sulfate in skeletal muscle induce uremic sarcopenia in chronic kidney disease.
Sato E; Mori T; Mishima E; Suzuki A; Sugawara S; Kurasawa N; Saigusa D; Miura D; Morikawa-Ichinose T; Saito R; Oba-Yabana I; Oe Y; Kisu K; Naganuma E; Koizumi K; Mokudai T; Niwano Y; Kudo T; Suzuki C; Takahashi N; Sato H; Abe T; Niwa T; Ito S
Sci Rep; 2016 Nov; 6():36618. PubMed ID: 27830716
[TBL] [Abstract][Full Text] [Related]
3. Sarcopenia in Chronic Kidney Disease: Factors, Mechanisms, and Therapeutic Interventions.
Watanabe H; Enoki Y; Maruyama T
Biol Pharm Bull; 2019; 42(9):1437-1445. PubMed ID: 31474705
[TBL] [Abstract][Full Text] [Related]
4. Sarcopenia in chronic kidney disease: from bench to bedside.
Kim DW; Song SH
Korean J Intern Med; 2023 May; 38(3):303-321. PubMed ID: 37077132
[TBL] [Abstract][Full Text] [Related]
5. Potential therapeutic interventions for chronic kidney disease-associated sarcopenia via indoxyl sulfate-induced mitochondrial dysfunction.
Enoki Y; Watanabe H; Arake R; Fujimura R; Ishiodori K; Imafuku T; Nishida K; Sugimoto R; Nagao S; Miyamura S; Ishima Y; Tanaka M; Matsushita K; Komaba H; Fukagawa M; Otagiri M; Maruyama T
J Cachexia Sarcopenia Muscle; 2017 Oct; 8(5):735-747. PubMed ID: 28608457
[TBL] [Abstract][Full Text] [Related]
6. Effects of hormonal changes on sarcopenia in chronic kidney disease: where are we now and what can we do?
Gungor O; Ulu S; Hasbal NB; Anker SD; Kalantar-Zadeh K
J Cachexia Sarcopenia Muscle; 2021 Dec; 12(6):1380-1392. PubMed ID: 34676694
[TBL] [Abstract][Full Text] [Related]
7. Low muscle mass is associated with progression of chronic kidney disease and albuminuria - An 8-year longitudinal study in Asians with Type 2 Diabetes.
Low S; Pek S; Moh A; Khin CYA; Lim CL; Ang SF; Wang J; Ang K; Tang WE; Lim Z; Subramaniam T; Sum CF; Lim SC
Diabetes Res Clin Pract; 2021 Apr; 174():108777. PubMed ID: 33745995
[TBL] [Abstract][Full Text] [Related]
8. New insights into muscle function in chronic kidney disease and metabolic acidosis.
Chalupsky M; Goodson DA; Gamboa JL; Roshanravan B
Curr Opin Nephrol Hypertens; 2021 May; 30(3):369-376. PubMed ID: 33767065
[TBL] [Abstract][Full Text] [Related]
9. Nutritional Strategies to Prevent Muscle Loss and Sarcopenia in Chronic Kidney Disease: What Do We Currently Know?
Massini G; Caldiroli L; Molinari P; Carminati FMI; Castellano G; Vettoretti S
Nutrients; 2023 Jul; 15(14):. PubMed ID: 37513525
[TBL] [Abstract][Full Text] [Related]
10. Association of advanced glycation end products with sarcopenia and frailty in chronic kidney disease.
Yabuuchi J; Ueda S; Yamagishi SI; Nohara N; Nagasawa H; Wakabayashi K; Matsui T; Yuichiro H; Kadoguchi T; Otsuka T; Gohda T; Suzuki Y
Sci Rep; 2020 Oct; 10(1):17647. PubMed ID: 33077879
[TBL] [Abstract][Full Text] [Related]
11. Impaired muscle mitochondrial energetics is associated with uremic metabolite accumulation in chronic kidney disease.
Thome T; Kumar RA; Burke SK; Khattri RB; Salyers ZR; Kelley RC; Coleman MD; Christou DD; Hepple RT; Scali ST; Ferreira LF; Ryan TE
JCI Insight; 2020 Dec; 6(1):. PubMed ID: 33290279
[TBL] [Abstract][Full Text] [Related]
12. Bone is Not Alone: the Effects of Skeletal Muscle Dysfunction in Chronic Kidney Disease.
Avin KG; Moorthi RN
Curr Osteoporos Rep; 2015 Jun; 13(3):173-9. PubMed ID: 25691218
[TBL] [Abstract][Full Text] [Related]
13. Association of skeletal muscle mass, kidney disease and mortality in older men and women: the cardiovascular health study.
Kruse NT; Buzkova P; Barzilay JI; Valderrabano RJ; Robbins JA; Fink HA; Jalal DI
Aging (Albany NY); 2020 Nov; 12(21):21023-21036. PubMed ID: 33139582
[TBL] [Abstract][Full Text] [Related]
14. Maintenance of Skeletal Muscle to Counteract Sarcopenia in Patients with Advanced Chronic Kidney Disease and Especially Those Undergoing Hemodialysis.
Mori K
Nutrients; 2021 May; 13(5):. PubMed ID: 34063269
[TBL] [Abstract][Full Text] [Related]
15. Muscle Atrophy in CKD: A Historical Perspective of Advancements in Its Understanding.
Price SR; Mitch WE; Garibotto G
J Ren Nutr; 2023 Nov; 33(6S):S88-S92. PubMed ID: 36183901
[TBL] [Abstract][Full Text] [Related]
16. Contribution of uremic dysbiosis to insulin resistance and sarcopenia.
Uchiyama K; Wakino S; Irie J; Miyamoto J; Matsui A; Tajima T; Itoh T; Oshima Y; Yoshifuji A; Kimura I; Itoh H
Nephrol Dial Transplant; 2020 Sep; 35(9):1501-1517. PubMed ID: 32535631
[TBL] [Abstract][Full Text] [Related]
17. Phosphate stimulates myotube atrophy through autophagy activation: evidence of hyperphosphatemia contributing to skeletal muscle wasting in chronic kidney disease.
Zhang YY; Yang M; Bao JF; Gu LJ; Yu HL; Yuan WJ
BMC Nephrol; 2018 Feb; 19(1):45. PubMed ID: 29486729
[TBL] [Abstract][Full Text] [Related]
18. Resistance exercise and nutritional interventions for augmenting sarcopenia outcomes in chronic kidney disease: a narrative review.
Noor H; Reid J; Slee A
J Cachexia Sarcopenia Muscle; 2021 Dec; 12(6):1621-1640. PubMed ID: 34585539
[TBL] [Abstract][Full Text] [Related]
19. Sarcopenia in chronic kidney disease.
Souza VA; Oliveira Dd; Mansur HN; Fernandes NM; Bastos MG
J Bras Nefrol; 2015; 37(1):98-105. PubMed ID: 25923756
[TBL] [Abstract][Full Text] [Related]
20. Hyperphosphatemia increases inflammation to exacerbate anemia and skeletal muscle wasting independently of FGF23-FGFR4 signaling.
Czaya B; Heitman K; Campos I; Yanucil C; Kentrup D; Westbrook D; Gutierrez O; Babitt JL; Jung G; Salusky IB; Hanudel M; Faul C
Elife; 2022 Mar; 11():. PubMed ID: 35302487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
